News anchor gets first shot in US Phase 3


Don Baker was a “bit nervous” but “really excited” on Monday when he made history.



A woman sitting in a chair talking on the phone: A screenshot of Elizabeth Cohen of CNN interviewing the first American participant to receive Modern's Phase 3 trial vaccine.


© c.n.n.
A screenshot of CNN’s Elizabeth Cohen interviewed the first American participant to receive Modern’s Phase 3 trial vaccine.

That morning, Baker, a news anchor at Georgia’s CNN affiliate WTOC in Savannah, became the first volunteer in the United States to receive injections in the first phase 3 clinical trial of a coronavirus vaccine.

Losing many lives and being affected by the coronovirus epidemic prompted Baker to volunteer.

Baker told CNN senior medical correspondent Elizabeth Cohen, “It’s really, very empowering for me that I can be the person who can help save some people. It’s very heartbreaking to hear about those people The one who lost his life. Monday at the Meridian Clinical Research Site in Sawan.

According to the cases of Johns Hopkins University in the United States, there are more than 4.2 million confirmed cases of coronovirus in the United States and at least 146,935 people have died.

“I never thought I’d do something like this,” Baker said. “I hope they are really, really good results. I know a lot of people are doing a lot of vaccine testing.”

A Kovid-19 vaccine race is underway around the world. According to the World Health Organization, at least 25 Kovid-19 vaccine candidates are being tested globally. Five of them are in Phase 3 trials, the most advanced phase of testing before a vaccine goes to market.

making history

The investigative Kovid-19 vaccine being tested in phase 3 trials in the United States was developed by biotechnology company Modern and the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. According to NIAID, the test is to be conducted at 89 US research sites.

It was “the fastest one to identify a virus, a pathogen, at a time when it actually goes into a phase 3 trial, literally at least in the history of vaccines in the United States, and perhaps worldwide. Also, ”NIAID Director Dr. Anthony Fauci said on Monday during the NIH event on Facebook Live.

The Phase 3 trial is expected to enroll about 30,000 adult volunteers to evaluate whether the modern / NIH vaccine can safely inhibit symptomatic covid-19 after two doses, among other outcomes. Volunteers will receive two 100 microgram injections of the vaccine or a placebo for approximately 28 days. Investigators and participants will not know who has received the vaccine.

Baker was not told whether he received the vaccine or the placebo. Shortly after receiving her shot, Baker told CNN’s Cohen that “it was painless” and before she even felt it.

While at the research site in Savannah, Baker thought of his colleague Lindsey Gough – who is influenced by coronoviruses.

Gough, a reporter at the WTOC news station, went from reporting on coronovirus to a positive test of Kovid-19 in late June. Goff, 27, spent 11 days in the hospital battling the disease.

“It really just broke my heart because she is such a young, strong, energetic young woman who is just on fire about what she does, and then to see her, she was so weak, and it Also to know what could happen to her. She lost her appendix due to Kovid, “said Baker, Gough is now at home.

‘We are all responsible for doing our part’

Monday was not the first time Baker has volunteered for medical reasons.

According to the bio on the news station WTOC’s website, Baker participated in a medical mission to Ghana with the Goodness and Mercy Foundation. She returned from that mission in June 2006. Then the following year, in February 2007, he participated in a medical mission with Vishwas that included a group called Vishwas. A few months later in September, she spent a week in Ajalli, Nigeria working with the Goodness and Mercy Foundation.

“It is my belief that we are all responsible for doing our part to improve the quality of life for our partner,” Baker wrote in his bio.

Now, Baker makes history not only as the first volunteer to get a shot at the Phase 3 trial – but also as a black female volunteer participating in the trial.

Black and brown communities have been hit hard by the coronovirus epidemic. Doctors are working to get a racially diverse group of volunteers participating in the vaccine study.

Baker said, “African Americans have a history – for good reason – being concerned about medicine. We are subject to all kinds of experiments, where we had no idea what was going on.” For example, in the infamous Tuskegee experiment, black men were subjects in a syphilis study without their consent, and were not offered penicillin to treat their disease.

“I’ve heard of many of my friends and even relatives who said that, you know, ‘I’m not going to be the first to get this vaccine. I don’t want to be a guinea pig. Wait and see what first. Happens. ’Baker said,“ So they are very suspicious. Maybe that’s why I was at least bold enough to come forward now, that might change that – which could ultimately save their lives, “Baker said.” I hope that maybe seeing my face gives them their opinion about that Will help change. “

Video: Here’s what Fauci thinks of the latest vaccine test (CNN)


Continue reading

Leave a Reply

Your email address will not be published.